Negative impactIPO

EAAA India Alternatives IPO Day 2: Subscribed 0.25x; QIB demand jumps 462% to 0.45x

scanx.trade 4 hrs ago·27 Oct 2026, 6:14 am

EAAA India Alternatives' IPO saw a muted response on its second trading day, with the issue subscribed only 0.25 times. The public subscription phase was largely driven by Qualified Institutional Buyers (QIBs), whose demand surged significantly. Their portion was subscribed 0.45 times, a sharp increase from the previous day's low levels. The remaining categories, including Non-Institutional Investors and Retail Individuals, saw little to no interest, indicating a lack of enthusiasm from these investor groups.

This uneven subscription pattern suggests that while institutional investors are cautiously optimistic, the broader market remains skeptical. The sharp jump in QIB demand highlights a divergence in sentiment, where large investors may see value that smaller investors are overlooking. For retail investors, the low subscription from their segment serves as a signal to proceed with caution. The stock's listing performance will be a key indicator of whether the institutional optimism is justified.

Excerpt from scanx.trade

Retail and NII segments saw marginal increases to 0.09x and 0.51x respectively. The issue closes on October 28, 2026. *this image is generated using AI for illustrative purposes only. EAAA India Alternatives IPO subscription climbed to 0.25 times on Day 2, propelled by a sharp 462% rise in QIB bids which reached…
Read the original at scanx.trade

Key takeaways

  • Category: IPO.
  • AI reads the tone as negative (potentially bearish) for the stock.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update worth tracking. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at scanx.trade.

More IPO news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.